PPT-PrEP and PEP After this presentation, participants will be able to:

Identify students at increased risk for HIV infection Implement CDC recommendations for PrEP amp PEP and know what the acronyms stand for Why relevant Why relevant Why relevant Act against HIV. Sample. 302 completed surveys by . TherapyEd Prep Class participants . 94.7% of survey respondents had taken the exam and received their results. 73.8% graduated from CAPTE accredited programs. 73.2% were first-time test takers. 1. A. Muhaari . 2. E. M. van der Elst . 2. D. Kowuor,. 2. A.Davies,. 2. C Agwanda, . 1. M. Price,. 3. F. Priddy,. 3. . H. S. Okuku,. 2 . S.M. Graham,. 4. E. J. Sanders . 2, 5 . Measuring sex acts in male sex workers in Kenya: . Nyaradzo M Mgodi (. MBChB. , . MMed. ). On behalf of the HPTN-076 Team. UZ-UCSF Annual Research Day. May 05, 2017 Harare. Background. Introduction to . Rilpivirine. (TMC 278). HPTN-076. Study Design. MSM . who practice chemsex? Results from a sub-study of the ANRS-IPERGAY trial. Roux P. 1. , . Fressard. . L. 1. , . Suzan. -Monti . M. 1. , . Chas. . J. 2. , . Capitant . C. 3. , . Meyer . L. 3. , . B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Bukusi. . Kenya Medical Research Institute. University of Washington. University of California, San Franscisco . . Adherence crucial for success of any clinical drug trial and/or treatment. Lulu Nair (MBChB, MPH). MTN 034/IPM 045 Protocol Chair . Satellite Session -24 July 2014. 9th IAS Conference on HIV Science (IAS 2017) Paris, France. Overview. Rationale for REACH (MTN 034/ IPM 045). Good Trainer. ”. AGENDA. Objectives of Presentation. Understanding Your Role and Audience. Effective Presentation Skills. How to Prepare . f. or a Session. How to . Maintain Control . of S. ession. The . South African experience. Sinead Delany-Moretlwe, . MBBCh. PhD. University of the Witwatersrand. IAS, 26 Jul 2018. TDF/FTC licensed for PrEP in . >40 countries. Included in WHO Essential Medicines List. OPTIONS 2018 HIV R4P Conference Neeraja Bhavaraju, FSG October 2018 Optimizing Prevention Technology Introduction On Schedule What is OPTIONS? The Optimizing Prevention Technology Introduction on Schedule (OPTIONS) Consortium is one of five microbicide projects funded by the U.S. Agency for International Development (USAID), in partnership with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), working to PrEP Considerations for HPX3002/HVTN 706 Susan Buchbinder HVTN Study Chair/San Francisco Site PI PrEP is safe and highly effective against sexual exposures for MSM and TGW 4 Doses/Week has Similar Efficacy to Daily TDF/FTC for MSM PrEP and Men: A man’s got to do, what a man’s got to do. Dr Saiqa Mullick, Wits RHI @ WitsRHI Share your thoughts on this presentation with #IAS2019 Context: It’s time for a conversation about male risk Basics of Injectable Cabotegravir. for HIV Prevention . Draft for Comment . AVAC. March 2022. Outline. What is cabotegravir (CAB)? . Treatment . Prevention . Clinical research. What users think . Regulatory and guidelines. Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTANCE ANALYSIS IN THE DISCOVER PREP TRIAL. Full-time employee and stockholder of Gilead.. Randomized. 1:1. Double blinded,. active controlled. MSM . or TGW. HIV Risk in a Population-based . PrEP. Study in Rural Kenya and Uganda: . Interim Results from the SEARCH Study. Catherine A. Koss. 1. , Diane V. Havlir. 1. , James Ayieko. 2. , . Dalsone. Kwarisiima.